Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis company. The Company is engaged in the production of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is also engaged in scientific research and the development of products and services, with patient safety as a guiding principle. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho).


CSE:THC - Post by User

Bullboard Posts
Post by MikeyStewon Nov 26, 2017 9:40pm
175 Views
Post# 27035063

Why THC Lags

Why THC LagsThe obvious is that THC has lagged its competitors for almost the entire time I’ve been in and out of this stock. I originally purchased last year in the $0.20s, rode the wave to $1.20s and sold, and rebought at $0.60 (with a few trades back and forth here and there). 

Why does THC lag behind it’s competition?  It’s simple. There have always been more questions than answers. I agree with Suncapital. There is an awful lot of opportunity with THC which is why I’m still invested. But the simple questions that people asked go unanswered, raise red flags, and this company doesn’t get the traction is should. Some examples:

1) The botched license release. Details unclearly released in MD&A. Never a clear answer.
2) Grow space. Always questioned by “bashers” here
3) Long term plan. No investor presentation to consult RE: current operating details and a long term plan
4) Shady backgrounds. Walsh and CFO haven’t had the cleanest of history.
5) Affinor deal. Don’t know if they ever installed the verticals grow system but the CEO was a Trump doppelgnger. Felt like he spent more time with Twitter wars than running a business.

So those are just some things that definitely left a bad taste in potential investor’s mouths in the last year. And once you have a bad reputation it’s tough to re-attract those investors.

Just my take. Hope something happens soon...
Bullboard Posts